The Market Reports

Index

1 Cyclophosphamide Market Overview
1.1 Product Overview and Scope of Cyclophosphamide
1.2 Cyclophosphamide Segment by Type
1.2.1 Global Cyclophosphamide Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 High-Dose
1.2.3 Low-Dose
1.3 Cyclophosphamide Segment by Application
1.3.1 Global Cyclophosphamide Sales Comparison by Application: (2021-2027)
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 AL Amyloidosis
1.3.5 Others
1.4 Global Cyclophosphamide Market Size Estimates and Forecasts
1.4.1 Global Cyclophosphamide Revenue 2016-2027
1.4.2 Global Cyclophosphamide Sales 2016-2027
1.4.3 Cyclophosphamide Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cyclophosphamide Market Competition by Manufacturers
2.1 Global Cyclophosphamide Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cyclophosphamide Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cyclophosphamide Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cyclophosphamide Manufacturing Sites, Area Served, Product Type
2.5 Cyclophosphamide Market Competitive Situation and Trends
2.5.1 Cyclophosphamide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cyclophosphamide Players Market Share by Revenue
2.5.3 Global Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cyclophosphamide Retrospective Market Scenario by Region
3.1 Global Cyclophosphamide Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Cyclophosphamide Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Cyclophosphamide Market Facts & Figures by Country
3.3.1 North America Cyclophosphamide Sales by Country
3.3.2 North America Cyclophosphamide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cyclophosphamide Market Facts & Figures by Country
3.4.1 Europe Cyclophosphamide Sales by Country
3.4.2 Europe Cyclophosphamide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cyclophosphamide Market Facts & Figures by Region
3.5.1 Asia Pacific Cyclophosphamide Sales by Region
3.5.2 Asia Pacific Cyclophosphamide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cyclophosphamide Market Facts & Figures by Country
3.6.1 Latin America Cyclophosphamide Sales by Country
3.6.2 Latin America Cyclophosphamide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cyclophosphamide Market Facts & Figures by Country
3.7.1 Middle East and Africa Cyclophosphamide Sales by Country
3.7.2 Middle East and Africa Cyclophosphamide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cyclophosphamide Historic Market Analysis by Type
4.1 Global Cyclophosphamide Sales Market Share by Type (2016-2021)
4.2 Global Cyclophosphamide Revenue Market Share by Type (2016-2021)
4.3 Global Cyclophosphamide Price by Type (2016-2021)

5 Global Cyclophosphamide Historic Market Analysis by Application
5.1 Global Cyclophosphamide Sales Market Share by Application (2016-2021)
5.2 Global Cyclophosphamide Revenue Market Share by Application (2016-2021)
5.3 Global Cyclophosphamide Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Baxter Cyclophosphamide Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Cyclophosphamide Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Corporation Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Hikma Pharmaceuticals Cyclophosphamide Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Amneal Pharmaceuticals LLC
6.4.1 Amneal Pharmaceuticals LLC Corporation Information
6.4.2 Amneal Pharmaceuticals LLC Description and Business Overview
6.4.3 Amneal Pharmaceuticals LLC Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Amneal Pharmaceuticals LLC Cyclophosphamide Product Portfolio
6.4.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
6.5 Jiangsu Hengrui Medicine
6.5.1 Jiangsu Hengrui Medicine Corporation Information
6.5.2 Jiangsu Hengrui Medicine Description and Business Overview
6.5.3 Jiangsu Hengrui Medicine Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Jiangsu Hengrui Medicine Cyclophosphamide Product Portfolio
6.5.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.6 NorthStar Rx LLC
6.6.1 NorthStar Rx LLC Corporation Information
6.6.2 NorthStar Rx LLC Description and Business Overview
6.6.3 NorthStar Rx LLC Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.6.4 NorthStar Rx LLC Cyclophosphamide Product Portfolio
6.6.5 NorthStar Rx LLC Recent Developments/Updates
6.7 GLS Pharma
6.6.1 GLS Pharma Corporation Information
6.6.2 GLS Pharma Description and Business Overview
6.6.3 GLS Pharma Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.4.4 GLS Pharma Cyclophosphamide Product Portfolio
6.7.5 GLS Pharma Recent Developments/Updates
6.8 CSC Pharmaceuticals International
6.8.1 CSC Pharmaceuticals International Corporation Information
6.8.2 CSC Pharmaceuticals International Description and Business Overview
6.8.3 CSC Pharmaceuticals International Cyclophosphamide Sales, Revenue and Gross Margin (2016-2021)
6.8.4 CSC Pharmaceuticals International Cyclophosphamide Product Portfolio
6.8.5 CSC Pharmaceuticals International Recent Developments/Updates

7 Cyclophosphamide Manufacturing Cost Analysis
7.1 Cyclophosphamide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cyclophosphamide
7.4 Cyclophosphamide Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cyclophosphamide Distributors List
8.3 Cyclophosphamide Customers

9 Cyclophosphamide Market Dynamics
9.1 Cyclophosphamide Industry Trends
9.2 Cyclophosphamide Growth Drivers
9.3 Cyclophosphamide Market Challenges
9.4 Cyclophosphamide Market Restraints

10 Global Market Forecast
10.1 Cyclophosphamide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cyclophosphamide by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cyclophosphamide by Type (2022-2027)
10.2 Cyclophosphamide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cyclophosphamide by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cyclophosphamide by Application (2022-2027)
10.3 Cyclophosphamide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cyclophosphamide by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cyclophosphamide by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Cyclophosphamide Sales (Person) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cyclophosphamide Sales (Person) Comparison by Application (2021-2027)
Table 3. Global Cyclophosphamide Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cyclophosphamide Covered in This Study
Table 5. Global Cyclophosphamide Sales (Person) of Key Manufacturers (2016-2021)
Table 6. Global Cyclophosphamide Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Cyclophosphamide Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cyclophosphamide Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cyclophosphamide Average Price (Average Cost/Person) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cyclophosphamide Manufacturing Sites and Area Served
Table 11. Manufacturers Cyclophosphamide Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cyclophosphamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclophosphamide as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cyclophosphamide Sales by Region (2016-2021) & (Person)
Table 16. Global Cyclophosphamide Sales Market Share by Region (2016-2021)
Table 17. Global Cyclophosphamide Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cyclophosphamide Sales by Country (2016-2021) & (Person)
Table 19. North America Cyclophosphamide Sales Market Share by Country (2016-2021)
Table 20. North America Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cyclophosphamide Revenue Market Share by Country (2016-2021)
Table 22. Europe Cyclophosphamide Sales by Country (2016-2021) & (Person)
Table 23. Europe Cyclophosphamide Sales Market Share by Country (2016-2021)
Table 24. Europe Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cyclophosphamide Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cyclophosphamide Sales by Region (2016-2021) & (Person)
Table 27. Asia Pacific Cyclophosphamide Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cyclophosphamide Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cyclophosphamide Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cyclophosphamide Sales by Country (2016-2021) & (Person)
Table 31. Latin America Cyclophosphamide Sales Market Share by Country (2016-2021)
Table 32. Latin America Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cyclophosphamide Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cyclophosphamide Sales by Country (2016-2021) & (Person)
Table 35. Middle East and Africa Cyclophosphamide Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cyclophosphamide Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cyclophosphamide Revenue Market Share by Country (2016-2021)
Table 38. Global Cyclophosphamide Sales (Person) by Type (2016-2021)
Table 39. Global Cyclophosphamide Sales Market Share by Type (2016-2021)
Table 40. Global Cyclophosphamide Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cyclophosphamide Revenue Share by Type (2016-2021)
Table 42. Global Cyclophosphamide Price (Average Cost/Person) by Type (2016-2021)
Table 43. Global Cyclophosphamide Sales (Person) by Application (2016-2021)
Table 44. Global Cyclophosphamide Sales Market Share by Application (2016-2021)
Table 45. Global Cyclophosphamide Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cyclophosphamide Revenue Share by Application (2016-2021)
Table 47. Global Cyclophosphamide Price (Average Cost/Person) by Application (2016-2021)
Table 48. Baxter Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 51. Baxter Cyclophosphamide Product
Table 52. Baxter Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 56. Novartis Cyclophosphamide Product
Table 57. Novartis Recent Developments/Updates
Table 58. Hikma Pharmaceuticals Corporation Information
Table 59. Hikma Pharmaceuticals Description and Business Overview
Table 60. Hikma Pharmaceuticals Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 61. Hikma Pharmaceuticals Cyclophosphamide Product
Table 62. Hikma Pharmaceuticals Recent Developments/Updates
Table 63. Amneal Pharmaceuticals LLC Corporation Information
Table 64. Amneal Pharmaceuticals LLC Description and Business Overview
Table 65. Amneal Pharmaceuticals LLC Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 66. Amneal Pharmaceuticals LLC Cyclophosphamide Product
Table 67. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 68. Jiangsu Hengrui Medicine Corporation Information
Table 69. Jiangsu Hengrui Medicine Description and Business Overview
Table 70. Jiangsu Hengrui Medicine Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 71. Jiangsu Hengrui Medicine Cyclophosphamide Product
Table 72. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 73. NorthStar Rx LLC Corporation Information
Table 74. NorthStar Rx LLC Description and Business Overview
Table 75. NorthStar Rx LLC Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 76. NorthStar Rx LLC Cyclophosphamide Product
Table 77. NorthStar Rx LLC Recent Developments/Updates
Table 78. GLS Pharma Corporation Information
Table 79. GLS Pharma Description and Business Overview
Table 80. GLS Pharma Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 81. GLS Pharma Cyclophosphamide Product
Table 82. GLS Pharma Recent Developments/Updates
Table 83. CSC Pharmaceuticals International Corporation Information
Table 84. CSC Pharmaceuticals International Description and Business Overview
Table 85. CSC Pharmaceuticals International Cyclophosphamide Sales (Person), Revenue (Million US$), Price (Average Cost/Person) and Gross Margin (2016-2021)
Table 86. CSC Pharmaceuticals International Cyclophosphamide Product
Table 87. CSC Pharmaceuticals International Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Cyclophosphamide Distributors List
Table 91. Cyclophosphamide Customers List
Table 92. Cyclophosphamide Market Trends
Table 93. Cyclophosphamide Growth Drivers
Table 94. Cyclophosphamide Market Challenges
Table 95. Cyclophosphamide Market Restraints
Table 96. Global Cyclophosphamide Sales Forecast by Type (2022-2027) & (Person)
Table 97. Global Cyclophosphamide Sales Market Share Forecast by Type (2022-2027)
Table 98. Global Cyclophosphamide Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 99. Global Cyclophosphamide Revenue Market Share Forecast by Type (2022-2027)
Table 100. Global Cyclophosphamide Sales Forecast by Application (2022-2027) & (Person)
Table 101. Global Cyclophosphamide Sales Market Share Forecast by Application (2022-2027)
Table 102. Global Cyclophosphamide Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 103. Global Cyclophosphamide Revenue Market Share Forecast by Application (2022-2027)
Table 104. Global Cyclophosphamide Sales Forecast by Region (2022-2027) & (Person)
Table 105. Global Cyclophosphamide Sales Market Share Forecast by Region (2022-2027)
Table 106. Global Cyclophosphamide Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 107. Global Cyclophosphamide Revenue Market Share Forecast by Region (2022-2027)
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cyclophosphamide
Figure 2. Global Cyclophosphamide Market Share by Type in 2020 & 2027
Figure 3. High-Dose Product Picture
Figure 4. Low-Dose Product Picture
Figure 5. Global Cyclophosphamide Market Share by Application in 2020 & 2027
Figure 6. Cancer
Figure 7. Autoimmune Diseases
Figure 8. AL Amyloidosis
Figure 9. Others
Figure 10. Global Cyclophosphamide Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Cyclophosphamide Market Size 2016-2027 (US$ Million)
Figure 12. Global Cyclophosphamide Sales 2016-2027 (Person)
Figure 13. Global Cyclophosphamide Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Cyclophosphamide Sales Share by Manufacturers in 2020
Figure 15. Global Cyclophosphamide Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Cyclophosphamide Players: Market Share by Revenue in 2020
Figure 17. Cyclophosphamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Cyclophosphamide Sales Market Share by Region (2016-2021)
Figure 19. Global Cyclophosphamide Sales Market Share by Region in 2020
Figure 20. Global Cyclophosphamide Revenue Market Share by Region (2016-2021)
Figure 21. Global Cyclophosphamide Revenue Market Share by Region in 2020
Figure 22. U.S. Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Cyclophosphamide Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Cyclophosphamide by Type (2016-2021)
Figure 47. Sales Market Share of Cyclophosphamide by Application (2016-2021)
Figure 48. Sales Market Share of Cyclophosphamide by Application in 2020
Figure 49. Revenue Share of Cyclophosphamide by Application (2016-2021)
Figure 50. Revenue Share of Cyclophosphamide by Application in 2020
Figure 51. Manufacturing Cost Structure of Cyclophosphamide
Figure 52. Manufacturing Process Analysis of Cyclophosphamide
Figure 53. Cyclophosphamide Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed